Similarly, hepatocellular carcinoma cell-derived exosomes deliver miR-210 as a signalling molecule to endothelial cells, and miR-210 promotes tumour angiogenesis through two targets, SMAD4 and STAT6 (27). Here, SMAD4 is linked to hepatocellular carcinoma.